Since, a bit like in T1DM, insulin therapy is practically the only valid weapon in gestational diabetes, another open issue remains for gestational diabetes, in which it could be a valid, safe and effective option, reducing the frequency of daily injections; more solid and future clinical data are needed in this regard. This evidence concerns the gene INS and type 1 diabetes mellitus.